Nanoparticle Delivery
Our nanoparticles are engineered to package and transport the
chemotherapy drug into the bloodstream.
Leveraging the Enhanced Permeability and Retention (EPR) effect, they accumulate in
tumor tissue more efficiently than in healthy tissue.
Prodrug Activation
The chemotherapy drug we use is initially in a non-toxic, inactive
form, known as a prodrug.
This ensures that the drug only becomes active at the tumor site, reducing systemic
toxicity.
Ultrasound Activation
Our method uses ultrasound waves to trigger the conversion
of the prodrug into its active form at the tumor site.
This targeted activation minimizes damage to healthy tissues and enhances the
drug’s efficacy.